Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China
· Delayed Price · Currency is CNY 48.17
-1.35 (-2.73%)
Apr 29, 2026, 3:04 PM CST
Betta Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 421.01 | 429.98 | 471.68 | 752 | 731.28 | 791.99 | Upgrade
|
| Trading Asset Securities | 89.23 | 66 | 126.44 | 0.54 | - | 201.01 | Upgrade
|
| Cash & Short-Term Investments | 510.23 | 495.98 | 598.12 | 752.54 | 731.28 | 993 | Upgrade
|
| Cash Growth | -14.64% | -17.08% | -20.52% | 2.91% | -26.36% | -35.35% | Upgrade
|
| Accounts Receivable | 512.46 | 351.26 | 98.47 | 286.41 | 450.62 | 173.38 | Upgrade
|
| Other Receivables | 20.47 | 77.95 | 1.83 | 2.61 | 49.7 | 40.75 | Upgrade
|
| Receivables | 532.93 | 429.21 | 100.3 | 289.02 | 500.32 | 214.13 | Upgrade
|
| Inventory | 351.68 | 381.16 | 290.09 | 327.5 | 372.17 | 293.32 | Upgrade
|
| Prepaid Expenses | - | - | - | 0.2 | - | - | Upgrade
|
| Other Current Assets | 275.64 | 271.48 | 235.82 | 156.62 | 129.06 | 153.49 | Upgrade
|
| Total Current Assets | 1,670 | 1,578 | 1,224 | 1,526 | 1,733 | 1,654 | Upgrade
|
| Property, Plant & Equipment | 2,926 | 2,962 | 3,009 | 2,574 | 2,056 | 1,331 | Upgrade
|
| Long-Term Investments | 2,539 | 2,583 | 1,437 | 1,382 | 919.27 | 345.79 | Upgrade
|
| Goodwill | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | Upgrade
|
| Other Intangible Assets | 2,749 | 2,604 | 2,776 | 1,944 | 1,219 | 1,183 | Upgrade
|
| Long-Term Accounts Receivable | - | 13.28 | 9.29 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 59.48 | 59.13 | 56.73 | 39.13 | 85.96 | 55.06 | Upgrade
|
| Long-Term Deferred Charges | 227.04 | 220.16 | 383.53 | 1,219 | 1,444 | 1,252 | Upgrade
|
| Other Long-Term Assets | 103.4 | 133 | 32.7 | 50.3 | 39.3 | 37.6 | Upgrade
|
| Total Assets | 10,688 | 10,566 | 9,342 | 9,147 | 7,910 | 6,271 | Upgrade
|
| Accounts Payable | 417.94 | 512.32 | 746.11 | 800.12 | 35.85 | 431.19 | Upgrade
|
| Accrued Expenses | 90.65 | 390.16 | 285.53 | 357.82 | 419.11 | 357.02 | Upgrade
|
| Short-Term Debt | 5.03 | 5 | 100.08 | 300.27 | 380.39 | - | Upgrade
|
| Current Portion of Long-Term Debt | 801.39 | 824.19 | 639.85 | 301.25 | - | - | Upgrade
|
| Current Portion of Leases | - | 46.65 | 33.03 | 4.6 | 4.16 | 4.88 | Upgrade
|
| Current Income Taxes Payable | 94.9 | 47.24 | 4.26 | 0.07 | 0.04 | 10.68 | Upgrade
|
| Current Unearned Revenue | 5.31 | 2.37 | 2.63 | 4.92 | 4.46 | 0.69 | Upgrade
|
| Other Current Liabilities | 271.21 | 89.36 | 36.47 | 34.11 | 1,261 | 84.4 | Upgrade
|
| Total Current Liabilities | 1,686 | 1,917 | 1,848 | 1,803 | 2,105 | 888.86 | Upgrade
|
| Long-Term Debt | 1,703 | 1,524 | 1,552 | 1,816 | 656.03 | - | Upgrade
|
| Long-Term Leases | 51.21 | 62.84 | 71.63 | 8.18 | 7.3 | 6.34 | Upgrade
|
| Long-Term Unearned Revenue | 184.36 | 226.22 | 150.99 | 144.7 | 112.76 | 112 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 162.49 | 167.91 | 53.49 | 23.39 | 71.57 | 68.39 | Upgrade
|
| Other Long-Term Liabilities | 37.74 | - | - | - | - | 510.06 | Upgrade
|
| Total Liabilities | 3,826 | 3,898 | 3,676 | 3,795 | 2,952 | 1,586 | Upgrade
|
| Common Stock | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | Upgrade
|
| Additional Paid-In Capital | 2,168 | 2,164 | 2,076 | 2,142 | 1,860 | 1,932 | Upgrade
|
| Retained Earnings | 3,292 | 3,056 | 2,834 | 2,503 | 2,181 | 2,139 | Upgrade
|
| Comprehensive Income & Other | 914.47 | 954.47 | 245.21 | 188.3 | 390.99 | 74.64 | Upgrade
|
| Total Common Equity | 6,795 | 6,595 | 5,574 | 5,251 | 4,849 | 4,561 | Upgrade
|
| Minority Interest | 67.78 | 72.53 | 92.3 | 100.4 | 108.64 | 124.9 | Upgrade
|
| Shareholders' Equity | 6,863 | 6,668 | 5,666 | 5,351 | 4,958 | 4,686 | Upgrade
|
| Total Liabilities & Equity | 10,688 | 10,566 | 9,342 | 9,147 | 7,910 | 6,271 | Upgrade
|
| Total Debt | 2,561 | 2,462 | 2,396 | 2,430 | 1,048 | 11.22 | Upgrade
|
| Net Cash (Debt) | -2,051 | -1,966 | -1,798 | -1,678 | -316.59 | 981.77 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | -35.97% | Upgrade
|
| Net Cash Per Share | -4.89 | -4.70 | -4.29 | -4.00 | -0.76 | 2.36 | Upgrade
|
| Filing Date Shares Outstanding | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | Upgrade
|
| Total Common Shares Outstanding | 420.73 | 420.73 | 418.49 | 418.49 | 417.47 | 415.39 | Upgrade
|
| Working Capital | -15.94 | -339.45 | -623.63 | -277.28 | -371.95 | 765.08 | Upgrade
|
| Book Value Per Share | 16.15 | 15.68 | 13.32 | 12.55 | 11.62 | 10.98 | Upgrade
|
| Tangible Book Value | 3,632 | 3,577 | 2,384 | 2,894 | 3,216 | 2,964 | Upgrade
|
| Tangible Book Value Per Share | 8.63 | 8.50 | 5.70 | 6.92 | 7.70 | 7.14 | Upgrade
|
| Buildings | - | 3,041 | 2,952 | 586.14 | 585.59 | 627.19 | Upgrade
|
| Machinery | - | 461.18 | 449.64 | 424.26 | 402.25 | 376.01 | Upgrade
|
| Construction In Progress | - | 227.31 | 191.87 | 2,037 | 1,448 | 639.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.